Page last updated: 2024-10-30

leflunomide and Acute Edematous Pancreatitis

leflunomide has been researched along with Acute Edematous Pancreatitis in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stosic-Grujicic, S1
Dimitrijevic, M1
Bartlett, R1

Other Studies

1 other study available for leflunomide and Acute Edematous Pancreatitis

ArticleYear
Leflunomide protects mice from multiple low dose streptozotocin (MLD-SZ)-induced insulitis and diabetes.
    Clinical and experimental immunology, 1999, Volume: 117, Issue:1

    Topics: Animals; Autoimmune Diseases; Blood Glucose; Diabetes Mellitus, Type 1; Dose-Response Relationship,

1999